Osaic Holdings’s XORTX Therapeutics XRTX Stock Holding History

Osaic Holdings’s Portfolio XRTX Stock Details XRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-231	Closed	-$1.3K	–	7739
2024 Q4	$1.3K	Hold	231	–	–	﹤0.01%	6753
2024 Q3	$1.89K	Hold	231	–	–	﹤0.01%	6635
2024 Q2	$2.19K	Hold	231	–	–	﹤0.01%	6563
2024 Q1	$4.27K	Hold	231	–	–	﹤0.01%	6165
2023 Q4	$2.66K	Buy	231 +205	+788%	+$15.1K	﹤0.01%	6423
2023 Q3	$6.23K	Hold	26	–	–	﹤0.01%	6170
2023 Q2	$6.74K	Hold	26	–	–	﹤0.01%	6173
2023 Q1	$4.83K	Buy	26 +17	+189%	+$4.27K	﹤0.01%	6333
2022 Q4	$3K	Hold	9	–	–	﹤0.01%	6550
2022 Q3	$4K	Buy	+9	New	+$5.07K	﹤0.01%	6528

Other funds holding XRTX

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Osaic Holdings's XRTX Position: Q1 2025 in Review

Osaic Holdings sold out of XORTX Therapeutics (XRTX) in Q1 2025, closing a stake of 231 shares — an estimated $1.3K sold.

Osaic Holdings first reported a position in XRTX in Q3 2022 and held it in 10 quarters. The position peaked at $6.74K in Q2 2023. 2 funds tracked by Wall St. Rank hold XRTX as of Q1 2025.

Osaic Holdings reported no remaining XORTX Therapeutics position as of Q1 2025 after selling out during the quarter.
Osaic Holdings sold 231 XORTX Therapeutics shares in Q1 2025, an estimated $1.3K.
Osaic Holdings first reported a position in XORTX Therapeutics in Q3 2022 and held it in 10 quarters.
Osaic Holdings's XORTX Therapeutics position peaked at $6.74K in Q2 2023.
2 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.